EVALUATING DRUGS AFTER THEIR APPROVAL FOR CLINICAL USE - REPLY

被引：0

作者：

RAY, WA ^{[1
]}

GRIFFIN, MR ^{[1
]}

AVORN, J ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1994年 / 330卷 / 19期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1394 / 1395

页数：2

共 50 条

[21] Understanding and evaluating clinical trials - Reply
Bigby, M
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (05) : 804 - 805
[22] USE OF ANTIASTHMATIC DRUGS IN AUSTRALIA - REPLY
JENKINS, M
BOWES, G
MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (01) : 72 - 72
[23] CAUTION IN THE USE OF DRUGS IN THE ELDERLY - REPLY
THOMPSON, TL
MORAN, MG
NIES, AS
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (26): : 1601 - 1601
[24] USE OF NONAPPROVED DRUGS IN CHILDREN - REPLY
KAUFFMAN, RE
JOURNAL OF PEDIATRICS, 1992, 120 (04): : 668 - 669
[25] Use of psychoactive drugs in children REPLY
Parsonson, Barry
JOURNAL OF PRIMARY HEALTH CARE, 2009, 1 (02) : 160 - 160
[26] APPROVAL OF NEW DRUGS
WIENER, H
SCIENCE, 1973, 181 (4095) : 110 - &
[27] The clinical impact of new antiepileptic drugs after a decade of use in epilepsy
Schmidt, D
EPILEPSY RESEARCH, 2002, 50 (1-2) : 21 - 32
[28] Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits
Sachs, Rachel E.
Jazowski, Shelley A.
Gavulic, Kyle A.
Donohue, Julie M.
Dusetzina, Stacie B.
JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2022, 47 (06) : 673 - 690
[29] Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
Liu, Ian T. T.
Kesselheim, Aaron S.
Cliff, Edward R. Scheffer
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (17): : 1471 - 1479
[30] Clinical Development and Regulatory Approval of Acute Heart Failure Drugs in Japan
Shinagawa, Kaori
CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 107 - 109

← 1 2 3 4 5 →